2021 欧洲共识:COPD急性院内加重的标准化临床评估、管理和随访

2021-02-16 国外呼吸科专家组(统称) Int J Chron Obstruct Pulmon Dis . 2021 Feb 16;16:321-332.

尽管COPD因急性加重而住院时发病率和死亡率的高风险事件,但全球范围内对于COPD住院加重的的评估和管理尚未形成共识。本文主要目的是建立院内COPD急性加重的评估、管理和随访标准。

中文标题:

2021 欧洲共识:COPD急性院内加重的标准化临床评估、管理和随访

英文标题:

Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide Consensus

发布日期:

2021-02-16

简要介绍:

尽管COPD因急性加重而住院时发病率和死亡率的高风险事件,但全球范围内对于COPD住院加重的的评估和管理尚未形成共识。本文主要目的是建立院内COPD急性加重的评估、管理和随访标准。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 欧洲共识:COPD急性院内加重的标准化临床评估、管理和随访.pdf)] GetToolGuiderByIdResponse(projectId=1, id=ea9381c0020e308a, title=2021 欧洲共识:COPD急性院内加重的标准化临床评估、管理和随访, enTitle=Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide Consensus, guiderFrom=Int J Chron Obstruct Pulmon Dis . 2021 Feb 16;16:321-332., authorId=0, author=, summary=尽管COPD因急性加重而住院时发病率和死亡率的高风险事件,但全球范围内对于COPD住院加重的的评估和管理尚未形成共识。本文主要目的是建立院内COPD急性加重的评估、管理和随访标准。, cover=https://img.medsci.cn/2021325/1616685181437_2020535.jpg, journalId=0, articlesId=null, associationId=1219, associationName=国外呼吸科专家组(统称), associationIntro=国外呼吸科专家组(统称), copyright=0, guiderPublishedTime=Tue Feb 16 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>尽管COPD因急性加重而住院时发病率和死亡率的高风险事件,但全球范围内对于COPD住院加重的的评估和管理尚未形成共识。本文主要目的是建立院内COPD急性加重的评估、管理和随访标准。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=295, tagName=COPD)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=295, guiderKeyword=COPD, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3655, appHits=181, showAppHits=0, pcHits=433, showPcHits=3474, likes=2, shares=11, comments=7, approvalStatus=1, publishedTime=Thu Mar 25 23:31:11 CST 2021, publishedTimeString=2021-02-16, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Mar 25 23:13:06 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 13:50:54 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 欧洲共识:COPD急性院内加重的标准化临床评估、管理和随访.pdf)])
2021 欧洲共识:COPD急性院内加重的标准化临床评估、管理和随访.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1084488, encodeId=b60c10844880e, content=哇!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78006425683, createdName=ms4000000925425693, createdTime=Sun Dec 26 21:56:41 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004972, encodeId=805810049e22e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb55558156, createdName=马小胖, createdTime=Tue Aug 03 21:32:12 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953013, encodeId=7d619530132d, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85531588690, createdName=baijerrywu, createdTime=Thu Apr 01 10:31:20 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952952, encodeId=88fd95295206, content=copd管理,至关重要,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e72611914, createdName=江南雪晴, createdTime=Wed Mar 31 22:51:11 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952140, encodeId=67dc95214022, content=很好,感谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/d701dc26df2c4b2385d0cf07543da176/9c816891eb564929ac67a864960af425.jpg, createdBy=f8c91671521, createdName=1de11937m40(暂无匿称), createdTime=Mon Mar 29 20:43:00 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
    2021-12-26 ms4000000925425693

    哇!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1084488, encodeId=b60c10844880e, content=哇!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78006425683, createdName=ms4000000925425693, createdTime=Sun Dec 26 21:56:41 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004972, encodeId=805810049e22e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb55558156, createdName=马小胖, createdTime=Tue Aug 03 21:32:12 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953013, encodeId=7d619530132d, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85531588690, createdName=baijerrywu, createdTime=Thu Apr 01 10:31:20 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952952, encodeId=88fd95295206, content=copd管理,至关重要,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e72611914, createdName=江南雪晴, createdTime=Wed Mar 31 22:51:11 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952140, encodeId=67dc95214022, content=很好,感谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/d701dc26df2c4b2385d0cf07543da176/9c816891eb564929ac67a864960af425.jpg, createdBy=f8c91671521, createdName=1de11937m40(暂无匿称), createdTime=Mon Mar 29 20:43:00 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
    2021-08-03 马小胖

    不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1084488, encodeId=b60c10844880e, content=哇!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78006425683, createdName=ms4000000925425693, createdTime=Sun Dec 26 21:56:41 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004972, encodeId=805810049e22e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb55558156, createdName=马小胖, createdTime=Tue Aug 03 21:32:12 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953013, encodeId=7d619530132d, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85531588690, createdName=baijerrywu, createdTime=Thu Apr 01 10:31:20 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952952, encodeId=88fd95295206, content=copd管理,至关重要,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e72611914, createdName=江南雪晴, createdTime=Wed Mar 31 22:51:11 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952140, encodeId=67dc95214022, content=很好,感谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/d701dc26df2c4b2385d0cf07543da176/9c816891eb564929ac67a864960af425.jpg, createdBy=f8c91671521, createdName=1de11937m40(暂无匿称), createdTime=Mon Mar 29 20:43:00 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
    2021-04-01 baijerrywu

    实用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1084488, encodeId=b60c10844880e, content=哇!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78006425683, createdName=ms4000000925425693, createdTime=Sun Dec 26 21:56:41 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004972, encodeId=805810049e22e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb55558156, createdName=马小胖, createdTime=Tue Aug 03 21:32:12 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953013, encodeId=7d619530132d, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85531588690, createdName=baijerrywu, createdTime=Thu Apr 01 10:31:20 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952952, encodeId=88fd95295206, content=copd管理,至关重要,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e72611914, createdName=江南雪晴, createdTime=Wed Mar 31 22:51:11 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952140, encodeId=67dc95214022, content=很好,感谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/d701dc26df2c4b2385d0cf07543da176/9c816891eb564929ac67a864960af425.jpg, createdBy=f8c91671521, createdName=1de11937m40(暂无匿称), createdTime=Mon Mar 29 20:43:00 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
    2021-03-31 江南雪晴

    copd管理,至关重要,学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1084488, encodeId=b60c10844880e, content=哇!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78006425683, createdName=ms4000000925425693, createdTime=Sun Dec 26 21:56:41 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004972, encodeId=805810049e22e, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bdb55558156, createdName=马小胖, createdTime=Tue Aug 03 21:32:12 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953013, encodeId=7d619530132d, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85531588690, createdName=baijerrywu, createdTime=Thu Apr 01 10:31:20 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952952, encodeId=88fd95295206, content=copd管理,至关重要,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e72611914, createdName=江南雪晴, createdTime=Wed Mar 31 22:51:11 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952140, encodeId=67dc95214022, content=很好,感谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/d701dc26df2c4b2385d0cf07543da176/9c816891eb564929ac67a864960af425.jpg, createdBy=f8c91671521, createdName=1de11937m40(暂无匿称), createdTime=Mon Mar 29 20:43:00 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
    2021-03-29 1de11937m40(暂无匿称)

    很好,感谢分享。

    0

拓展阅读

2010 GOLD 慢性阻塞性肺疾病全球倡议:COPD诊断、治疗与预防全球策略

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2010-01-01

2010JRS 日本呼吸学会慢性阻塞性肺疾病(COPD)诊治指南(概述)

日本呼吸学会(JRS,the Japanese Respiratory Society) · 2010-02-01

2011 GOLD 慢性阻塞性肺疾病全球倡议:COPD诊断、治疗与预防全球策略

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2011-12-01

2013 GOLD 慢性阻塞性肺疾病全球倡议:COPD诊断、治疗与预防全球策略(修订版)

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2013-02-13

2013 西班牙COPD指南:慢性阻塞性肺疾病基于临床表型的分级和治疗

西班牙肺病和胸外科学会(SEPAR,Spanish Society of Pneumology and Thoracic Surgery) · 2013-03-20